Yuhao Zhang

Mr. Yuhao Zhang

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020
Verified
Journal Article
Closed access
BZB Zhang
B Zhang
YZYuhao Zhang
Yuhao Zhang
RLRunsheng Li
Runsheng Li
LZLei Zhao
Lei Zhao
SQShucun Qin
Shucun Qin
YGY-X Gao
Y-X Gao

25 January 2024 in Cancers
Verified
Journal Article
Open access
PDF file
YRYunzhao Ren
Yunzhao Ren
QWQINCHUAN WANG
QINCHUAN WANG
CXChenyang Xu
Chenyang Xu
QGQian Guo
Qian Guo
RDRuoqi Dai
Ruoqi Dai
HTHuakang Tu
Huakang Tu
Background: Recent studies have revealed that neutrophils play a crucial role in cancer progression. This study aimed to explore the diagnostic value of neutrophil-related biomarkers for non-small-cell lung cancer (NSCLC). Methods: We initially assessed the associations between classic neutrophil-related biomarkers (neutrophil-to-lymphocyte ratio (NLR), absolute neutrophil counts (NEU), absolute lymphocyte counts (LYM)) and NSCLC in 3942 cases and 6791 controls. Then, we measured 11 novel neutrophil-related biomarkers via Luminex Assays in 132 cases and 66 controls, individually matching on sex and age (±5 years), and evaluated their associations with NSCLC risk. We also developed the predictive models by sequentially adding variables of interest and assessed model improvement. Results: Interleukin-6 (IL-6) (odds ratio (OR) = 10.687, 95% confidence interval (CI): 3.875, 29.473) and Interleukin 1 Receptor Antagonist (IL-1RA) (OR = 8.113, 95% CI: 3.182, 20.689) shows strong associations with NSCLC risk after adjusting for body mass index, smoking status, NLR, and carcinoembryonic antigen. Adding the two identified biomarkers to the predictive model significantly elevated the model performance from an area under the receiver operating characteristic curve of 0.716 to 0.851 with a net reclassification improvement of 97.73%. Conclusions: IL-6 and IL-1RA were recognized as independent risk factors for NSCLC, improving the predictive performance of the model in identifying disease.